FABP3 (Fatty Acid Binding Protein 3): A Cardiac and Neuronal Lipid Chaperone
Explore the genomic context, tissue expression, disease associations, and functional role of FABP3, a key player in fatty acid transport and cellular signaling.
Gene Information Card
| Symbol | FABP3 |
|---|---|
| Full Name | Fatty Acid Binding Protein 3 |
| Gene Type | protein coding |
| Chromosomal Location | 1p35.2 |
| NCBI Gene ID | 2170 ncbi.nlm.nih.gov/gene/2170 |
| Ensembl ID | ENSG00000121769 |
| UniProt ID | P05413 |
| OMIM ID | 134651 |
| HGNC ID | 3557 |
| Aliases | H-FABP, MDGI, O-FABP, MGC48 |
Description
The FABP3 gene encodes the heart-type fatty acid binding protein (H-FABP), a small cytoplasmic protein abundantly expressed in cardiac and skeletal muscle, as well as in specific brain regions. As a member of the fatty acid binding protein family, FABP3 acts as a lipid chaperone, facilitating the intracellular transport of long-chain fatty acids from the plasma membrane to sites of beta-oxidation (mitochondria) and signaling (nucleus). Beyond its role in lipid metabolism, FABP3 is involved in gene regulation, cell growth, and differentiation. Its release into the bloodstream upon myocardial injury makes it a sensitive biomarker for acute coronary syndrome and other cardiac conditions. Furthermore, altered FABP3 expression is implicated in various neurological and metabolic disorders.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Disease | Mechanism | Evidence |
| Myocardial Infarction | Rapid release of cytosolic FABP3 into the bloodstream following cardiomyocyte necrosis or ischemia. | ClinVar, PubMed (Extensive literature) |
| Heart Failure | Elevated circulating FABP3 levels correlate with disease severity and prognosis, reflecting ongoing myocardial stress and remodeling. | PubMed (Multiple studies) |
| Alzheimer's Disease | Increased FABP3 expression in the brain and cerebrospinal fluid, potentially linked to amyloid-beta toxicity and neuroinflammation. | PubMed (Case-control studies) |
| Schizophrenia | Altered FABP3 expression in the prefrontal cortex, suggesting a role in neuronal lipid metabolism and synaptic function. | PubMed (Post-mortem brain studies) |
| Type 2 Diabetes | FABP3 may influence insulin sensitivity and lipid handling in muscle and adipose tissue, contributing to metabolic dysregulation. | PubMed (Genetic association studies) |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Tissue | nTPM | Level |
| Heart | 1253.4 | High |
| Skeletal Muscle | 1102.8 | High |
| Brain (Cerebellum) | 78.2 | Medium |
| Adipose Tissue | 45.1 | Medium |
| Liver | 3.2 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| Cell Line | nTPM | Notes |
| RH-30 (Rhabdomyosarcoma) | 152.4 | High expression in muscle-derived tumor cell line. |
| SK-UT-1 (Uterine Leiomyosarcoma) | 98.7 | Elevated expression in smooth muscle tumor cells. |
| SH-SY5Y (Neuroblastoma) | 12.3 | Moderate expression in neuronal-like cells. |
| HepG2 (Hepatocellular Carcinoma) | 1.8 | Low expression in liver cancer cell line. |
| A549 (Lung Carcinoma) | 0.9 | Minimal expression in lung epithelial cancer cells. |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| Variant | Type | Frequency | Effect |
| rs2241883 (T94T) | Synonymous SNP | High (MAF ~0.3) | No known functional effect on protein sequence; may influence mRNA stability. |
| rs2271326 (c.87C>T) | Missense SNP (p.Gly29=) | Low (MAF <0.01) | Silent mutation; no amino acid change. |
| c.199G>A (p.Ala67Thr) | Missense Mutation | Rare | Reported in a single case of dilated cardiomyopathy; functional impact uncertain, may alter protein stability. |
Mutation functional classification
Loss of Function (LOF)
Complete loss-of-function mutations in FABP3 are rare and likely not viable due to its essential role in cardiac fatty acid metabolism. Partial loss-of-function variants could impair fatty acid transport, potentially contributing to metabolic cardiomyopathies.
Gain of Function (GOF)
No clear gain-of-function mutations have been described. Overexpression of FABP3, rather than mutation, is observed in certain cancers and may promote cell proliferation and lipid accumulation.
Dominant Negative (DN)
No evidence for dominant-negative effects of FABP3 mutations. As a monomeric protein, a mutant allele is unlikely to interfere with the function of the wild-type protein.
View complete mutation data:
Gene Ontology (GO)
| • fatty acid binding | • lipid binding |
| • transporter activity | • intracellular lipid transport |
| • fatty acid metabolic process | • long-chain fatty acid transport |
| • response to oxidative stress | • regulation of cell growth |
| • negative regulation of cell population proliferation |
Pathways
• PPAR signaling pathway
• Fatty acid metabolism
• Cardiac muscle contraction (indirect)
• Transport of fatty acids
Protein Summary
The FABP3 protein, also known as H-FABP, is a 15 kDa cytoplasmic protein that binds long-chain fatty acids with high affinity. Its structure consists of a beta-barrel formed by ten antiparallel beta-strands, creating a hydrophobic cavity for ligand binding. FABP3 facilitates the diffusion of fatty acids from the plasma membrane to intracellular organelles, playing a critical role in energy production in tissues with high oxidative capacity, such as the heart. It also interacts with nuclear receptors, potentially modulating gene expression related to lipid metabolism and cell survival. Upon myocardial damage, FABP3 is rapidly released into the circulation, serving as an early and sensitive biomarker for acute myocardial infarction and other cardiac pathologies.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| FABP3 Knockout HEK293 Cell Line | EDJ-KQ1119 | Human | 2170 | Details Get a Quote |
| FABP3 Knockout HeLa Cell Line | EDJ-KQ20308 | Human | 2170 | Details Get a Quote |
| FABP3 Knockout A-549 Cell Line | EDJ-KQ61676 | Human | 2170 | Details Get a Quote |
| FABP3 Knockout HCT 116 Cell Line | EDJ-KQ70159 | Human | 2170 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records